Interview with SZA, Grammy-Winning Artist, on Breast Cancer Risk, the Grammys, and Being Herself

SZA joins Dr. Thais Aliabadi and Mary Alice Haney to talk about the startling risk estimates of breast cancer, especially when it changes after more information becomes available. SZA’s experience offers a useful example: her initial estimated lifetime risk was 53%, then fell to about 27% after her clinician incorporated additional information. Her genetic test was negative, but her revised risk still called for a conversation about earlier breast imaging.

We can use her experience to understand what a lifetime risk estimate means, why family history matters even when genetic testing is negative, and how to ask better questions about screening. SZA also reflects on health anxiety, the heartbreak behind her music, the pressure of the Grammys, and why she no longer feels obliged to fit someone else’s idea of a “nice girl.”

Table of Contents

• Breast cancer risk: The questions behind SZA’s experience
• Breast findings and decisions that need follow-up
• Health anxiety, trust, and self-advocacy
• Creativity, recognition, and life beyond a risk score
• What can we do with these lessons?

Breast cancer risk: The questions behind SZA’s experience

What prompted SZA to take a closer look at her breast cancer risk?

SZA had a personal reason to ask questions: her mother had breast cancer, and her aunt had undergone a mastectomy. She had also been evaluated for a breast mass that was identified as a fibroadenoma, a benign growth.

Those details do not tell us, on their own, whether someone will develop cancer. They do tell us why a routine assumption based only on age would be incomplete. We need to consider family history, the findings from any breast evaluation, and the information used in a formal risk assessment.

SZA’s mother was doing well years after her diagnosis. That is reassuring for her family, but it does not erase the importance of recording the diagnosis when assessing SZA’s own risk. Likewise, a benign finding is good news about that particular mass; it does not answer every future screening question.

What is a lifetime breast cancer risk estimate?

A lifetime breast cancer risk estimate is a calculation of someone’s chance of developing breast cancer over the remainder of their life. It is not a diagnosis, and it is not a prediction that cancer will appear at a particular age.

We build the estimate from information entered into a risk model. In SZA’s assessment, Dr. Thaïs Aliabadi discussed factors including family history, height and weight, reproductive history, the age menstruation began, breast density, and genetic test results. The estimate can change when an important detail is added or corrected.

That is why we should read a risk percentage as a tool for planning care, not as a verdict. For a fuller explanation of what questionnaires and models consider, see how breast cancer risk assessments work.

How did SZA’s estimate change from 53% to about 27%?

The first calculation used the information available at the time, including her family history, but did not yet include everything Dr. Aliabadi later learned about her breast density and genetic test results. Once those details were available, the revised estimate was about 27%.

We should not interpret that change as cancer risk suddenly disappearing. It means the calculation became more informed. The distinction matters because about 27% remained above the 20% threshold Dr. Aliabadi used to discuss earlier breast imaging.

If we receive two different risk scores, our next question should be: “What changed between the calculations?” We can ask which model was used, which family-history details were entered, whether breast density was known, and whether the newer score changes the screening plan. A number is most useful when we understand the information and decisions behind it.

Does a negative genetic test rule out breast cancer?

No. SZA’s genetic testing did not identify a mutation on the panel used, yet her calculated lifetime breast cancer risk remained elevated. We cannot treat a negative result as a promise that breast cancer will not develop, or as proof that family history no longer matters.

Genetic testing and a risk calculation answer different questions. Testing looks for certain inherited changes. A risk assessment brings together multiple factors, including family history, to guide a broader discussion about future care. Dr. Aliabadi emphasized using both pieces of information rather than stopping at a negative test result.

We also need to be precise about the word “negative.” It describes the result of the test performed, not the absence of every possible health risk. Anyone uncertain about what their panel covered should review the report with the clinician who ordered it.

Does breast cancer risk matter if no one in our family has had it?

Yes. Family history can affect a calculation, but a person does not need a known family history to have breast cancer risk. Dr. Aliabadi cited an average lifetime risk of roughly 12.5% to illustrate why “it does not run in my family” is not the same as “it cannot happen to me.”

We should also avoid treating any single percentage as an emergency. The useful question is what our individual estimate means for screening and follow-up. If family history is incomplete, we can tell our clinician what we do know rather than assuming missing information means no risk.

When should someone with elevated lifetime risk discuss breast imaging?

In SZA’s case, Dr. Aliabadi identified a lifetime risk above 20% as a reason to discuss starting breast imaging at age 30 rather than simply waiting until 40. The point is not that every person with a similar score should arrange the same test on their own. The point is that a risk estimate may change when and how screening is considered.

We can bring our calculated score, family history, prior imaging, biopsy results, and genetic report to an appointment and ask for an individualized plan. The plan should specify what imaging is recommended, when to begin, and how often to return. Some women with risk factors may benefit from screening earlier than a schedule intended for average-risk women, as discussed in this overview of earlier mammography for some women.

Waiting until a lump can be felt is not a substitute for a recommended screening plan. SZA noted that she could not feel anything unusual after a gap in follow-up, but Dr. Aliabadi stressed that imaging is intended to find concerns before they are apparent by touch. We should keep scheduled follow-up even when our breasts feel normal.

Breast findings and decisions that need follow-up

What should we take away from SZA’s fibroadenoma and biopsy experience?

A fibroadenoma is a benign breast mass. SZA described having a sample taken and a small marker placed in her breast during the evaluation of a finding. The important distinction is between what was learned about that finding and what follow-up is still needed because of overall risk.

We should keep copies of imaging and biopsy reports, including information about any marker placed during a procedure. If later care changes the breast, those records help clinicians understand what was found, sampled, or treated before. SZA described subsequent breast surgery and uncertainty about a marker afterward, which illustrates why sharing the full procedure history matters at future imaging appointments.

Her experience should not be read as a general rule that people with dense breasts cannot have implants. She reported pain and scar tissue after getting implants and later had them removed. Those are her personal outcomes, not a diagnosis we can apply to someone else. If we are considering a breast procedure, we should review our risk assessment, existing findings, and follow-up obligations with the clinicians involved before proceeding.

What if we have missed recommended breast follow-up?

We can restart with the next practical step rather than waiting until we feel completely prepared. SZA acknowledged a substantial gap in checking back and had arranged a new appointment. That combination is familiar: we may care deeply about our health and still delay an uncomfortable task.

A simple catch-up checklist can help:

• Contact the clinician or imaging center. Explain when the last evaluation occurred and ask what should be scheduled now.
• Gather prior records. Include imaging, biopsy results, genetic testing, and notes about breast surgery or markers.
• Update family history. Tell the care team about relatives’ cancer diagnoses or procedures that were not previously recorded.
• Confirm the plan before leaving. Ask what result to expect, who will contact us, and when the next follow-up is due.

We do not need to self-diagnose a new symptom before requesting an appointment. We do need to tell a clinician about a new or changing breast concern rather than relying on an older benign result to explain it. An overview of breast cancer warning signs and diagnostic methods can help us prepare questions, but it cannot replace an examination or individualized advice.

Health anxiety, trust, and self-advocacy

How does SZA describe her relationship with medical uncertainty?

SZA is candid about how quickly an unexplained symptom can become frightening. She had sought help for rashes and allergies, discussed a positive antinuclear antibody result with a rheumatologist, and learned more about concerns such as testosterone levels and PCOS. She also described worrying about swollen lymph nodes and other symptoms that required a clinician’s assessment.

We should not turn those details into diagnoses. A positive ANA result, for example, was part of an ongoing evaluation in her account, not confirmation that she had lupus. Her larger point is about the strain of not knowing what a symptom means while information and possibilities accumulate.

For SZA, trust grew because she felt her concerns were taken seriously, explained calmly, and referred onward when needed. We can want reassurance and still want a careful evaluation. Those needs are not opposites.

How can we advocate for ourselves without letting every symptom become a crisis?

We can separate three tasks that often get tangled together: noticing a symptom, getting it assessed, and imagining every possible explanation. The first two help us obtain care. The third may leave us overwhelmed before we have enough information.

Before an appointment, we can write down when a symptom began, what has changed, what we have already tried, and the specific question we want answered. During the visit, we can ask:

• What are you considering, and why?
• What findings would change the plan?
• Do we need a test, a referral, or a period of follow-up?
• When should we contact you again?

Being an advocate does not require us to arrive with our own diagnosis. It means we communicate clearly, ask when something is unclear, and follow through on the agreed plan. SZA values a clinician who can distinguish between a concern that needs further investigation and one that can be explained without dismissing how frightening it feels.

Why does representation matter when describing symptoms?

SZA recalled difficulty finding online examples that resembled the way a skin condition appeared on her mother’s darker skin. Images showing redness on lighter skin did not help her understand changes that looked different on her mother’s palms and feet.

We should not assume an online photograph provides the full range of how a condition can appear. When describing a skin change to a clinician, we can be specific about its color, location, sensation, timing, and progression. If a search result seems inconsistent with what we see, that is a reason to ask better questions, not to dismiss the symptom or decide on a diagnosis ourselves.

Access to a clinician who listens also matters. SZA spoke about the relief of having someone she trusted to help direct a question to the appropriate specialist. We may not have that relationship immediately, but we can still ask for an explanation, a referral when appropriate, and a clear next step.

Can family experiences make health questions feel more urgent?

Yes. SZA connects some of her vigilance to serious illnesses among people she loves. Dr. Aliabadi also described the lasting fear that can follow a personal cancer diagnosis. We do not need to judge that fear as irrational to recognize that it can make an ordinary symptom harder to put in perspective.

A useful response is neither to ignore every concern nor to search indefinitely for the worst-case explanation. We can bring the concern to a qualified clinician, describe the family experience that shapes our worry, and ask what information would help resolve the immediate question. Emotional context belongs in the conversation alongside medical facts.

Creativity, recognition, and life beyond a risk score

How does heartbreak find its way into SZA’s music?

SZA draws on early relationships, first heartbreaks, and experiences she continued to process later. She described a long relationship and engagement, as well as earlier transitions that taught her a great deal about love. Rather than limiting a song to something that happened recently, she can revisit an old feeling from a different point in her life.

For her, making the work can be a way of processing it. Once a song is finished, she does not habitually return to the recording for that purpose. We can hear the vulnerability in the finished music without assuming that every lyric describes her present-day circumstances.

What does SZA say about success and the people around her?

Despite the scale of her career, SZA repeatedly credits the musicians, producers, friends, and manager she trusts. She described moments on tour when being far from home made the reach of her work feel especially real. The recognition can be exhilarating, but it can also be difficult to absorb while the work continues.

Her approach to collaboration is notably practical. She wants to create with excellent people and does not frame every room around being its only woman. We can take that as her account of her own working relationships, not as a claim that gender never affects anyone else’s experience in music.

How did SZA feel about her Grammy nominations?

She described a mix of gratitude and fear when discussing nine nominations and the approaching ceremony. She wanted her parents there and was thinking about how to get through a high-pressure evening, not simply counting possible wins. The conversation took place before that ceremony; the introduction later noted that she won three awards that year.

That contrast helps us understand why public milestones and private feelings do not always match. We can celebrate an artist’s recognition without assuming that a major event feels effortless from the inside.

What does SZA mean by no longer trying to be a “nice girl”?

For SZA, the phrase is not a rejection of kindness. It is a rejection of the idea that she must always be soft-spoken, agreeable, or easy for others to understand. She admires her mother’s gentle manner but has come to accept that her own curiosity, intensity, and willingness to challenge things are part of who she is.

She also recognizes that strength needs judgment. The drive that helps her question assumptions and get things done can be difficult for people around her when it has no pause. She described working through childhood experiences in therapy and learning to make room for different sides of herself rather than pretending the sharper ones do not exist.

We do not have to choose between being considerate and having an opinion. The more useful question is whether we are expressing ourselves honestly while remaining aware of how our actions affect other people.

What advice does SZA offer young artists about well-being and the internet?

She encourages more time away from constant online input. That does not mean she sees the internet as an enemy of creativity. She finds inspiration there and recognizes that it can expose us to ideas we might adapt in our own way.

Her concern is the absence of space to process what we take in. If we are continually scrolling, searching, and reacting, it becomes harder to notice which ideas genuinely interest us. We can make that advice practical by setting aside periods without a feed, returning to an unfinished idea, and allowing ourselves time to think before seeking more material.

What might SZA tell her younger self?

She would ease up on guilt and hold on to belief in what she could do. Long before the career she has now, she imagined an ambitious future without knowing exactly which profession would take her there. She remembers the younger version of herself as unusually willing to picture something big and move toward it.

At the same time, she has been reconsidering how much her self-worth should depend on being first, respected, or understood by everyone. We can pursue excellent work without making external approval the only measure of whether our lives are going well.

Her curiosity is also turning toward interests beyond music, including agriculture. She presents that as an interest she is exploring, not a completed venture. It is a reminder that even a well-established career does not have to define the limits of what we may want to learn next.

What can we do with these lessons?

SZA’s health story gives us a clear distinction to carry into our own appointments: a negative genetic test, a benign breast finding, and breasts that feel normal do not replace an individualized screening discussion. We can ask how a lifetime risk estimate was calculated, update it when new information becomes available, and make sure we understand the follow-up plan.

We can also bring our uncertainty into the room. Family experiences, fear, and a desire to understand every detail can coexist with sound medical care. The next step is not to become our own diagnostician. It is to gather what we know, ask specific questions, and work with a qualified clinician on a plan we can actually follow.

Medical note: This article is for education and is not a substitute for personal medical advice. Breast symptoms, risk estimates, genetic results, and screening decisions should be reviewed with a qualified healthcare professional.